The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

The food industry is facing a Perfect Storm - assaults on ultra-processed foods; warning labels; and the rise of GLP-1 drug ...

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The program, called 340b, allows eligible safety net providers to purchase drugs at deeply discounted prices, then reinvest ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...